PILLDirexion Daily Pharmaceutical & Medical Bull 3X Shares ETF
Seeks daily investment results of 300% of the daily performance of the Index.
By Direxion Funds · Launched 2017
0.98%
#5,069 of 5,861 · expensive
$20M
#4,473 of 5,861 · small
+232.1%
8 years
#1,639 of 5,861 · established
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaStrategy
Leveraged
Sector
Health careIndex tracked
S&P Pharmaceuticals & Medical Equipment & Devices Select Industry Index
What it actually holds
By weightConcentration
synthetic exposure — holdings shown are derivatives collateral, not the fund's positions
Asset allocation
By sector
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsYear-on-year price swings
Worst peak-to-trough loss
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks daily investment results of 300% of the daily performance of the Index.
- Strategy
- Invests primarily in pharmaceutical and medical stocks to achieve 3X daily leveraged exposure to the Index. The Fund is designed to measure performance of stocks in the pharmaceuticals industry, classified under GICS, and rebalances its portfolio daily to maintain this exposure.
- Inception date
- November 15, 2017
- Fund family
- Direxion Funds
Similar funds
Same asset class, closest by strategy & exposureOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Your return drifts the longer you hold
Leverage amplifies the index's daily move, by 2x or 3x. The fund resets every day, so over weeks and months your real return drifts from that multiple. It can run ahead in a smooth climb and bleed in a choppy one. Hold one for months and you own a different bet than the label suggests.
Sources: Cheng & Madhavan, 'The Dynamics of Leveraged and Inverse ETFs' (2009)
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've looked at PILL. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04